Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study
Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced. TNBC with less than 1% androgen receptor (AR) expression may respond to enzalutamide with greater response association in higher levels. A metr...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2021-05-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkjpath.org/pdf.php3?id=1951
|